It has been demonstrated that CASC2 was low-expressed in the cisplatin-resistant cervical cancer tissues compared to cisplatin-sensitive cancer tissues and overexpression of CACS2 sensitized cisplatin-resistant cervical cancer cells to cisplatin (9). Here, CASC2 is linked to cervical cancer.